EphrinB2-Mediated CDK5/ISL1 Pathway Enhances Cardiac Lymphangiogenesis and Alleviates Ischemic Injury by Resolving Post-MI Inflammation

Scientists revealed that erythropoietin-producing hepatoma interactor B2 (EphrinB2) prevented ischemic heart post-myocardial infarction from remodeling and dysfunction by activating the cardiac lymphangiogenesis signaling pathway.